Clinical Trials Logo
  1. Home
  2. Opioid Dependency
  3. NCT00955162

Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France ("RIME") — RIME  

Opioid Dependency Clinical Trial

Official title:
A Multicentre, Randomised, Open-label, Active-controlled Trial of the Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France

Clinical Trial Summary

Patients who admit to using buprenorphine by the intravenous route will be randomized to either Subutex or Suboxone and be followed up for 3 months to determine if there is less injection with Suboxone than with Subutex based primarily on patient diaries.

Patients randomized to Suboxone may continue to receive the product for a further 9 months at their request and will be monitored at 3 month intervals.

Patients will receive a payment for the inconvenience of keeping a daily diary and to cover their travel expenses.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00955162
Study type Interventional
Source Indivior Inc.
Contact
Status Completed
Phase Phase 4
Start date August 2009
Completion date May 2011
View Details
See also
  Status Clinical Trial Phase
Terminated NCT00772785 - Study of Probuphine in Patients With Opioid Dependence Phase 3
Completed NCT00591617 - Optimizing Outcomes Using Suboxone for Opiate Dependence N/A
Completed NCT01075971 - Study of Two Formulations of Buprenorphine HCl in Opioid-dependent Subjects on Buprenorphine Maintenance Therapy (Study P04451) (COMPLETED) Phase 2
Completed NCT00913484 - Disulfiram for Cocaine Abuse in Buprenorphine Treatment Phase 2
Completed NCT01262261 - Re-Treatment Study of Probuphine in Opioid Addiction Phase 3
Terminated NCT00269607 - Naltrexone Implants as Relapse Prevention Phase 2/Phase 3
Completed NCT00577005 - Efficacy of Levetiracetam in Cocaine-Abusing Methadone Maintained Patients Phase 2
Completed NCT01806389 - A Study of Breastfeeding in Buprenorphine Maintained Women N/A
Completed NCT00727675 - Chronic Pain and Opioid Dependence Assessment and Treatment N/A
Completed NCT00742170 - Transdermal Electroacupuncture for Opioid Detoxification Phase 1/Phase 2
Completed NCT01114308 - A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction Phase 3
Completed NCT00877591 - Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications Phase 1